<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03483493</url>
  </required_header>
  <id_info>
    <org_study_id>Hollis201117</org_study_id>
    <nct_id>NCT03483493</nct_id>
  </id_info>
  <brief_title>Online Remote Behavioural Intervention for Tics (ORBIT)</brief_title>
  <acronym>ORBIT</acronym>
  <official_title>Therapist-guided, Parent-assisted Remote Digital Behavioural Intervention for Tics in Children and Adolescents With Tourette Syndrome: an Internal Pilot Study and Single-blind Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nottinghamshire Healthcare NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University College, London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NIHR MindTech MedTech Co-operative</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Great Ormond Street Hospital for Children NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Nottingham</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nottinghamshire Healthcare NHS Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Online Remote Behavioural Intervention for Tics (ORBIT).&#xD;
&#xD;
      Primary objective: to evaluate the clinical effectiveness of BiP Tic, a therapist-guided,&#xD;
      parent-assisted, internet-based behavioural therapy intervention for tics in young people,&#xD;
      compared with usual care plus online education.&#xD;
&#xD;
      Secondary objectives include 1) optimising the design of the intervention, 2) undertaking an&#xD;
      internal pilot, 3) evaluating cost effectiveness and 4) longer term impact, and 5)&#xD;
      identifying barriers to implementation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ORBIT (Online Remote Behavioural Intervention for Tics) trial is comparing the&#xD;
      effectiveness of two treatments delivered online for children and young people with Tourette&#xD;
      Syndrome or Chronic Tic Disorder. Families in England with a child/young person (aged 9-17&#xD;
      years) who experiences tics are being asked to take part. Interested families undergo a&#xD;
      telephone screen with a researcher and then asked to complete an online questionnaire. They&#xD;
      then attend a screening appointment at either Great Ormond Street Hospital (London) or&#xD;
      Queen's Medical Centre (Nottingham).&#xD;
&#xD;
      Families that are eligible and want to take part are randomly allocated to one of two&#xD;
      treatments. One treatment uses behavioural therapy (BT), the other involves psychoeducation.&#xD;
      Both treatments last for 10-weeks and involve completing online chapters (for the parent and&#xD;
      child) with the support of a therapist, there are also some tasks to complete offline. After&#xD;
      finishing the treatment, families are asked to complete more questionnaires (at 3, 6, 12 and&#xD;
      18 months after starting the treatment). A smaller sample of families and healthcare&#xD;
      professionals are also interviewed about their experience of participation. The study is&#xD;
      looking to see if the online delivered treatment may be effective at helping children and&#xD;
      young people manage their tics. The study is also exploring whether the online programme is&#xD;
      acceptable to families, identifying any problems in getting families to take part/complete&#xD;
      the programme and also healthcare professionals' views about the programme. It is important&#xD;
      to research online therapy for tics because, at the moment, many people with tics do not get&#xD;
      any therapy because there are not enough trained tic therapists. If online delivered&#xD;
      treatment is effective, this may mean more children and young people could access tic&#xD;
      therapy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 7, 2018</start_date>
  <completion_date type="Actual">April 12, 2021</completion_date>
  <primary_completion_date type="Actual">February 18, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessing change in tics in participants using the Yale Global Tic Severity Scale - Total Tic score</measure>
    <time_frame>Baseline, 3, 6, 12 and 18 months</time_frame>
    <description>Investigator administered semi structured symptom checklist of 46 tic disorder symptoms. The Total Tic Score is derived by adding the Total Motor Tic Score and the Total Phonic Tic Score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessing change in tics in participants using the Parent Tic Questionnaire</measure>
    <time_frame>Baseline, 5wks, 3mths, 6mths, 12mths &amp; 18 months</time_frame>
    <description>Self administered questionnaire to collect the number, frequency and intensity of 14 common motor and 14 common vocal tics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing change in symptom severity/improvement in participants using the Clinical Global Impressions Scale.</measure>
    <time_frame>3, 6, 12 &amp; 18 months</time_frame>
    <description>Clinician determined measure that summarises the patient's history, symptoms, behaviours and psychosocial circumstances</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing change in tic impairment in participants using the Yale Global Tic Severity Scale Impairment Scale (assessing change)</measure>
    <time_frame>Baseline, 3, 6, 12 &amp; 18 months</time_frame>
    <description>This forms part of the YGTSS but focuses on distress and impairment experienced in the individuals life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing change in global functioning in participants using the Children's Global Assessment Scale</measure>
    <time_frame>Baseline, 3, 6, 12 &amp; 18 months</time_frame>
    <description>A measure of psychiatric disturbance integrating psychological, social and academic functioning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing change in general functioning in participants using the Strengths and Difficulties Questionnaire</measure>
    <time_frame>Baseline, 3, 6, 12 &amp; 18 months</time_frame>
    <description>Self-report, parent completed questionnaire measuring behavioural and emotional difficulties in children. The baseline SDQ is completed as part of a screening tool &quot;DAWBA&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing change in mood in participants using the Mood and Feelings Questionnaire</measure>
    <time_frame>Baseline, 1, 3, 6, 12 &amp; 18 months</time_frame>
    <description>Child completed, self-report questionnaire collecting information on depressive symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing change in anxiety in participants using the Spence Child Anxiety Scale</measure>
    <time_frame>Baseline, 3, 6, 12 &amp; 18 months</time_frame>
    <description>Self-report child completed questionnaire evaluating symptoms of separation anxiety, social phobia, obsessive-compulsive disorder, pain, agoraphobia, generalised anxiety and fear of physical injury</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing change in quality of life in participants using the Child Health Utility 9D</measure>
    <time_frame>Baseline, 3, 6,12,18 months</time_frame>
    <description>Self-report parent and child completed quality of life measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing change in tic-related quality of life in participants using the Child and Adolescent Gilles de la Tourette Syndrome</measure>
    <time_frame>Baseline, 3, 6, 12 &amp; 18 months</time_frame>
    <description>A disease specific measure of health related quality of life for children and adolescents with Tourette Syndrome. There are two version, one for children aged 6-12 years and a second for young people aged 3-8 years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing participants change in use of services using the Modified Client Service Receipt Inventory</measure>
    <time_frame>Baseline, 3, 6, 12 &amp; 18 months</time_frame>
    <description>A questionnaire to collect information on services received, service related issues, school attendance and family income</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing change in side effects in participants using the Adverse events/side effects</measure>
    <time_frame>Baseline, 1, 3, 6, 12 &amp; 18 months</time_frame>
    <description>A 17 item scale of common side effects</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing participants perception of treatment credibility using a specifically created 'treatment credibility' questionnaire</measure>
    <time_frame>3 weeks</time_frame>
    <description>A two item questionnaire to assess how well the treatment suits children, according to the perception of the 1) parent/carer and 2) child/young person</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing participants perception of treatment satisfaction using a specifically created 'treatment satisfaction' questionnaire</measure>
    <time_frame>3 months</time_frame>
    <description>A 7 item scale questionnaire developed for the study to assess treatment satisfaction from the perception of the 1) parent/carer and 2) child/young person</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing participants perception of their need for further treatment using a specifically created 'Need for further treatment' questionnaire</measure>
    <time_frame>3 months</time_frame>
    <description>A single item questionnaire asking if the child or young person requires more treatment for their tics from the perception of the 1) parent/carer and 2) child/young</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing participants change of use of other medication/interventions using a specifically created 'Concomitant interventions' questionnaire</measure>
    <time_frame>Baseline, 3, 6, 12 &amp; 18 months</time_frame>
    <description>Assessment of any other treatment or interventions the child or young person is accessing during the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Describing sample characteristics using Development and Wellbeing Assessment (DAWBA) at screening/baseline</measure>
    <time_frame>Screening/Baseline</time_frame>
    <description>The DAWBA is a package of interviews and questionnaires completed by parents and teachers and designed to generate ICD-10 and DSM-IV / DSM-5 psychiatric diagnoses for children and young people.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determining presence of an intellectual disability at screening/baseline using the Child and Adolescent Intellectual Disability Screening Questionnaire (CAIDS-Q)</measure>
    <time_frame>Screening/Baseline</time_frame>
    <description>A 7-item questionnaire to determine the presence of intellectual disability at screening/baseline, completed by the parent/</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Understanding the characteristics of the sample a specifically created demographics questionnaire at screening/baseline</measure>
    <time_frame>Screening/Baseline</time_frame>
    <description>Parent completed questionnaire asking about the child's age, gender, ethnicity, parental education/ occupation, list of the child's current diagnoses and interventions (including medications) and GP and school details.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determining the for presence of Autism Spectrum Disorder using the Social Communication Questionnaire (SCQ) at screening/baseline</measure>
    <time_frame>Screening/Baseline</time_frame>
    <description>A 40 item, parent-report questionnaire asking about characteristic autistic behaviour at the age of 4 to 5 years and currently.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing Premonitory urges for tics using the Premonitory Urge for Tics Scale (PUTS) at screening/baseline</measure>
    <time_frame>Screening/Baseline</time_frame>
    <description>A self-report instrument specifically designed to measure the current frequency of different types of premonitory urges in patients with tic disorders</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing ADHD symptoms using the Swanson, Nolan, and Pelham Rating Scale (SNAP-IV) at screening/baseline</measure>
    <time_frame>Screening/Baseline</time_frame>
    <description>A parent completed 26-item behavioural rating scale that employs the core symptoms of ADHD and oppositional defiance disorder (ODD) as defined by the Diagnostic and Statistical Manual of Mental Disorders.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>To assess the process evaluation of the interventions qualitative interviews will be conducted</measure>
    <time_frame>3months</time_frame>
    <description>A sub-sample of participants will be as asked to participate in qualitative interviews as part of a process evaluation.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">224</enrollment>
  <condition>Tic Disorders</condition>
  <condition>Tourette Syndrome</condition>
  <arm_group>
    <arm_group_label>Exposure Response Prevention for tics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10-weeks, online delivered, therapist supported exposure response prevention (ERP) therapy for tics</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active Control (Psychoeducation)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10-weeks, online delivered, therapist supported psychoeducation for tics</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exposure Response Prevention for tics</intervention_name>
    <description>The intervention consists of evidence-based interventions adapted from previously published treatment manuals on Exposure and Response Prevention (ERP) and established behavioural intervention for tics protocols. Each of the 10 modules includes age-appropriate texts, animations and exercises. Prticipants are instructed to practice suppressing their tics, this is known as 'response prevention'. Then, with the help of their parent/carer, the participant is instructed to provoke premonitory urges (the urge to tic often felt before the tic is expressed) and try to supress the need to express/demonstrate the tic, this known as 'exposure'.</description>
    <arm_group_label>Exposure Response Prevention for tics</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Psychoeducation for tics</intervention_name>
    <description>The comparator intervention reviews the definition of tics, natural history, common presentations, prevalence, aetiology, risks and protective factors and strategies for describing tics to other people etc. Problem-solving and development of expertise in tic disorders is emphasised. The intervention includes strategies for promoting positive behaviours which will be rewarded by a parent as a parallel element to the tic control practice in the behavioural therapy arm. There is no information on tic control within the management package.</description>
    <arm_group_label>Active Control (Psychoeducation)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Aged 9 to 17: patient confirmed through screening.&#xD;
&#xD;
          2. Suspected or confirmed Tourette syndrome/ chronic tic disorder:&#xD;
&#xD;
             - Including Moderate/severe tics: Score &gt;15 on the Yale Global Tic Severity Scale&#xD;
             (YGTSS) Total Tic Severity Score (TTSS); TTSS score&gt;10 if motor or vocal tics only:&#xD;
             researcher confirms at screening appointment&#xD;
&#xD;
          3. Competent to provide written, informed consent (parental consent for child aged &lt;16):&#xD;
             researcher confirms at screening appointment.&#xD;
&#xD;
          4. Broadband internet access and regular PC/ laptop/Mac user, with mobile phone SMS:&#xD;
             patient confirmed through screening.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Previous structured behavioural intervention for tics e.g. HRT/CBIT or exposure and&#xD;
             response prevention within last 12 months: Patient confirmed through screening.&#xD;
&#xD;
          2. Change to medication for tics (start or stop tic medication) within the previous 2&#xD;
             months: Patient confirmed through screening and subsequent medication/interventions&#xD;
             commenced throughout out the trial are recorded at each time point for analysis.&#xD;
&#xD;
          3. Diagnoses of alcohol/substance dependence, psychosis, suicidality, or anorexia&#xD;
             nervosa: Confirmed through parent DAWBA. DAWBAs that score people as being likely to&#xD;
             have these conditions will be second reviewed by the CI (who is a medical expert) to&#xD;
             ascertain that they should definitely be excluded from the trial. If the child is&#xD;
             considered at immediate risk of suicide, the research team will inform the GP or usual&#xD;
             treating clinician.&#xD;
&#xD;
          4. Moderate/severe intellectual disability: Confirmed through qualitative judgement of&#xD;
             the assessor at the telephone screen (and confirmed at baseline through CAIDS-Q)&#xD;
             through questions relating to type of school the child attends and previous diagnoses.&#xD;
&#xD;
          5. Immediate risk to self or others: Confirmed through screening questions and DAWBA. The&#xD;
             participants GP will be informed of this.&#xD;
&#xD;
          6. Parent or child not able to speak or read/write English: Patient confirmed through&#xD;
             screening by the assessor.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>9 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chris Hollis, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Nottingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nottinghamshire Healthcare NHS Foundation Trust</name>
      <address>
        <city>Nottingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <results_reference>
    <citation>Hollis C, Hall CL, Jones R, Marston L, Novere ML, Hunter R, Brown BJ, Sanderson C, Andr√©n P, Bennett SD, Chamberlain LR, Davies EB, Evans A, Kouzoupi N, McKenzie C, Heyman I, Khan K, Kilgariff J, Glazebrook C, Mataix-Cols D, Murphy T, Serlachius E, Murray E. Therapist-supported online remote behavioural intervention for tics in children and adolescents in England (ORBIT): a multicentre, parallel group, single-blind, randomised controlled trial. Lancet Psychiatry. 2021 Oct;8(10):871-882. doi: 10.1016/S2215-0366(21)00235-2. Epub 2021 Sep 1.</citation>
    <PMID>34480868</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 12, 2018</study_first_submitted>
  <study_first_submitted_qc>March 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2018</study_first_posted>
  <last_update_submitted>September 8, 2021</last_update_submitted>
  <last_update_submitted_qc>September 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tic disorders</keyword>
  <keyword>Tourette Syndrome</keyword>
  <keyword>Online delivered therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tourette Syndrome</mesh_term>
    <mesh_term>Tics</mesh_term>
    <mesh_term>Tic Disorders</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data are available for use by researchers with a sound research idea from priment@ucl.ac.uk</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Data will be made available beginning 3 months and ending 5 years after the specified trial outcome paper(s) is/are published.</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

